Stock Comparison

ARGX vs BEAM

argenx NV ADR and Beam Therapeutics Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

BEAM

Beam Therapeutics Inc

Healthcare

Valuation

Market Cap

$55.44B

$3.58B

P/E (TTM)

39.4

—

Forward P/E

34.0

—

Price/Sales

11.7

21.8

Price/Book

7.5

3.1

EV/EBITDA

33.9

-7.0

Dividend Yield

—

Profitability

Net Margin

31.40%

-40.20%

Operating Margin

30.00%

-337.80%

Return on Equity

20.20%

-5.77%

Return on Assets

8.86%

-15.80%

Growth (YoY)

Revenue Growth

62.60%

324.90%

Earnings Growth

114.00%

0.00%

Price & Risk

Beta

-0.0

2.2

52-Week High

$934.62

$36.88

52-Week Low

$510.06

$15.60

Analyst Target

$1,041.14

$51.07

Compare ARGX and BEAM your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.